Melissa McKirdy Hazen, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vestibular Diseases | 1 | 2021 | 217 | 0.670 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 3 | 2022 | 260 | 0.530 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2021 | 770 | 0.520 |
Why?
|
Immunologic Deficiency Syndromes | 5 | 2019 | 547 | 0.510 |
Why?
|
Rheumatology | 3 | 2023 | 576 | 0.420 |
Why?
|
Macrophage Activation Syndrome | 3 | 2022 | 111 | 0.390 |
Why?
|
Arthritis, Rheumatoid | 5 | 2023 | 3712 | 0.260 |
Why?
|
Homeodomain Proteins | 3 | 2020 | 2421 | 0.240 |
Why?
|
Synovial Fluid | 2 | 2021 | 394 | 0.200 |
Why?
|
Lung Diseases | 2 | 2023 | 1886 | 0.190 |
Why?
|
Autoimmunity | 3 | 2019 | 1349 | 0.190 |
Why?
|
Mannosidase Deficiency Diseases | 1 | 2019 | 3 | 0.180 |
Why?
|
alpha-Mannosidase | 1 | 2019 | 20 | 0.180 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 297 | 0.170 |
Why?
|
Eosinophilia | 1 | 2023 | 541 | 0.160 |
Why?
|
Child | 21 | 2023 | 77709 | 0.160 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2020 | 223 | 0.160 |
Why?
|
Cell Polarity | 1 | 2021 | 645 | 0.160 |
Why?
|
Immunoglobulin G | 4 | 2013 | 4560 | 0.140 |
Why?
|
T-Lymphocytes, Regulatory | 3 | 2021 | 2988 | 0.140 |
Why?
|
Immunomodulation | 1 | 2020 | 541 | 0.140 |
Why?
|
Vasculitis | 1 | 2020 | 519 | 0.140 |
Why?
|
Rheumatoid Factor | 1 | 2016 | 188 | 0.140 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2020 | 652 | 0.140 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2020 | 612 | 0.130 |
Why?
|
Polysaccharides | 2 | 2012 | 1053 | 0.120 |
Why?
|
Biological Products | 1 | 2023 | 860 | 0.120 |
Why?
|
Major Histocompatibility Complex | 1 | 2016 | 936 | 0.120 |
Why?
|
Antirheumatic Agents | 1 | 2023 | 1339 | 0.110 |
Why?
|
Th17 Cells | 1 | 2020 | 766 | 0.110 |
Why?
|
Autoantibodies | 3 | 2023 | 2035 | 0.110 |
Why?
|
Periodicity | 1 | 2013 | 363 | 0.100 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1855 | 0.100 |
Why?
|
HLA Antigens | 1 | 2016 | 1381 | 0.100 |
Why?
|
Galactose | 1 | 2012 | 306 | 0.090 |
Why?
|
Membrane Proteins | 1 | 2008 | 7880 | 0.090 |
Why?
|
Receptor, Anaphylatoxin C5a | 1 | 2011 | 90 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1790 | 0.090 |
Why?
|
Child, Preschool | 11 | 2021 | 41006 | 0.090 |
Why?
|
Education, Medical, Continuing | 1 | 2014 | 840 | 0.080 |
Why?
|
Arthritis, Experimental | 1 | 2011 | 291 | 0.080 |
Why?
|
Inflammation | 4 | 2022 | 10638 | 0.080 |
Why?
|
Receptors, IgG | 1 | 2011 | 582 | 0.070 |
Why?
|
Humans | 32 | 2023 | 744343 | 0.070 |
Why?
|
Infant | 8 | 2021 | 35136 | 0.070 |
Why?
|
Fever | 1 | 2013 | 1616 | 0.070 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2015 | 1861 | 0.070 |
Why?
|
Adolescent | 11 | 2022 | 85781 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2020 | 5853 | 0.070 |
Why?
|
Methotrexate | 1 | 2012 | 1727 | 0.060 |
Why?
|
Macrophage Activation | 1 | 2008 | 558 | 0.060 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10180 | 0.060 |
Why?
|
Glycosylation | 2 | 2019 | 1126 | 0.060 |
Why?
|
Quality Improvement | 2 | 2019 | 3749 | 0.060 |
Why?
|
DNA-Binding Proteins | 1 | 2020 | 9648 | 0.060 |
Why?
|
Female | 20 | 2022 | 380194 | 0.050 |
Why?
|
Hypertension, Pulmonary | 1 | 2013 | 1537 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Pain Measurement | 2 | 2022 | 3420 | 0.050 |
Why?
|
Consensus | 2 | 2022 | 2959 | 0.050 |
Why?
|
Heterozygote | 1 | 2008 | 2804 | 0.050 |
Why?
|
Lung | 1 | 2019 | 9856 | 0.050 |
Why?
|
Male | 17 | 2022 | 350118 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2012 | 4420 | 0.050 |
Why?
|
Interleukin-1 | 1 | 2023 | 1263 | 0.040 |
Why?
|
Pilot Projects | 2 | 2022 | 8324 | 0.040 |
Why?
|
Killer Cells, Natural | 1 | 2008 | 2133 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 426 | 0.040 |
Why?
|
Neutrophils | 1 | 2011 | 3719 | 0.040 |
Why?
|
Interleukin-12 | 1 | 2020 | 579 | 0.040 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2023 | 986 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 12072 | 0.040 |
Why?
|
Interferon Type I | 1 | 2020 | 542 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2021 | 1880 | 0.040 |
Why?
|
Th1 Cells | 1 | 2021 | 1057 | 0.030 |
Why?
|
Interferon-alpha | 1 | 2020 | 895 | 0.030 |
Why?
|
Glycogen Storage Disease Type IV | 1 | 2015 | 7 | 0.030 |
Why?
|
C-Reactive Protein | 2 | 2022 | 3778 | 0.030 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 546 | 0.030 |
Why?
|
Patient Transfer | 1 | 2022 | 761 | 0.030 |
Why?
|
Lymphangiectasis | 1 | 2015 | 17 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2020 | 1200 | 0.030 |
Why?
|
Alleles | 2 | 2016 | 6933 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2023 | 77449 | 0.030 |
Why?
|
Genetic Complementation Test | 1 | 2015 | 562 | 0.030 |
Why?
|
Cryopyrin-Associated Periodic Syndromes | 1 | 2013 | 16 | 0.030 |
Why?
|
Mevalonate Kinase Deficiency | 1 | 2013 | 19 | 0.030 |
Why?
|
Catalysis | 1 | 2015 | 761 | 0.030 |
Why?
|
CD40 Ligand | 1 | 2015 | 526 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2012 | 0.030 |
Why?
|
Young Adult | 4 | 2022 | 56430 | 0.030 |
Why?
|
Incidence | 2 | 2023 | 20947 | 0.030 |
Why?
|
Familial Mediterranean Fever | 1 | 2013 | 61 | 0.030 |
Why?
|
Stomatitis, Aphthous | 1 | 2013 | 53 | 0.030 |
Why?
|
Hereditary Autoinflammatory Diseases | 1 | 2013 | 39 | 0.030 |
Why?
|
Quality Indicators, Health Care | 1 | 2023 | 1831 | 0.030 |
Why?
|
Lymphadenitis | 1 | 2013 | 98 | 0.030 |
Why?
|
Patient Participation | 1 | 2022 | 1457 | 0.030 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2020 | 1573 | 0.030 |
Why?
|
Knee Joint | 1 | 2021 | 1680 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2013 | 264 | 0.030 |
Why?
|
Colchicine | 1 | 2013 | 243 | 0.030 |
Why?
|
Cost of Illness | 1 | 2022 | 1859 | 0.030 |
Why?
|
Pharyngitis | 1 | 2013 | 215 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2021 | 21746 | 0.020 |
Why?
|
Accreditation | 1 | 2014 | 450 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2183 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2020 | 3200 | 0.020 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2013 | 595 | 0.020 |
Why?
|
Receptor Cross-Talk | 1 | 2011 | 119 | 0.020 |
Why?
|
Hypersensitivity | 1 | 2019 | 1102 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2015 | 2839 | 0.020 |
Why?
|
Amino Acids | 1 | 2016 | 1736 | 0.020 |
Why?
|
Homozygote | 1 | 2015 | 1785 | 0.020 |
Why?
|
Ubiquitin | 1 | 2015 | 852 | 0.020 |
Why?
|
Cold Temperature | 1 | 2013 | 772 | 0.020 |
Why?
|
Phenotype | 2 | 2020 | 16365 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2023 | 4665 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 29063 | 0.020 |
Why?
|
Synovitis | 1 | 2011 | 209 | 0.020 |
Why?
|
Adult | 6 | 2020 | 214055 | 0.020 |
Why?
|
Inpatients | 1 | 2020 | 2518 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 4386 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3638 | 0.020 |
Why?
|
Prednisone | 1 | 2013 | 1574 | 0.020 |
Why?
|
Neutrophil Infiltration | 1 | 2011 | 390 | 0.020 |
Why?
|
Adoptive Transfer | 1 | 2011 | 844 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2016 | 1838 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4479 | 0.020 |
Why?
|
Mutation | 2 | 2013 | 29786 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6756 | 0.020 |
Why?
|
DNA Methylation | 1 | 2021 | 4286 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2015 | 1788 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3610 | 0.020 |
Why?
|
Emergencies | 1 | 2013 | 1170 | 0.020 |
Why?
|
Amyloidosis | 1 | 2013 | 795 | 0.020 |
Why?
|
Age of Onset | 1 | 2013 | 3271 | 0.020 |
Why?
|
Species Specificity | 1 | 2011 | 2478 | 0.020 |
Why?
|
NF-kappa B | 1 | 2015 | 2499 | 0.020 |
Why?
|
Pain | 1 | 2021 | 4986 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10388 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4149 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2015 | 2564 | 0.020 |
Why?
|
Monocytes | 1 | 2015 | 2596 | 0.020 |
Why?
|
Databases, Factual | 1 | 2020 | 7729 | 0.020 |
Why?
|
Phagocytosis | 1 | 2011 | 1539 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12788 | 0.020 |
Why?
|
Middle Aged | 5 | 2020 | 213383 | 0.020 |
Why?
|
Fibroblasts | 1 | 2015 | 4161 | 0.020 |
Why?
|
Cytokines | 1 | 2019 | 7322 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2016 | 25043 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15226 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12959 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 2282 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2015 | 13815 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2011 | 2765 | 0.010 |
Why?
|
Family | 1 | 2013 | 3147 | 0.010 |
Why?
|
Genotype | 1 | 2016 | 12951 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7279 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 2013 | 2133 | 0.010 |
Why?
|
Curriculum | 1 | 2014 | 3605 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5442 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10262 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2016 | 19229 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2013 | 5021 | 0.010 |
Why?
|
Cohort Studies | 2 | 2013 | 40561 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17446 | 0.010 |
Why?
|
Algorithms | 1 | 2019 | 13881 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39050 | 0.010 |
Why?
|
Registries | 1 | 2013 | 8089 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 15519 | 0.010 |
Why?
|
Sex Factors | 1 | 2010 | 10397 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20129 | 0.010 |
Why?
|
Risk Factors | 1 | 2023 | 72290 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15076 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2011 | 14557 | 0.010 |
Why?
|
Transcription Factors | 1 | 2015 | 12208 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 35421 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2011 | 21827 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2010 | 15540 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 63114 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2011 | 18029 | 0.010 |
Why?
|
United States | 1 | 2019 | 69872 | 0.010 |
Why?
|
Mice | 1 | 2011 | 81183 | 0.000 |
Why?
|
Aged | 1 | 2012 | 163280 | 0.000 |
Why?
|
Animals | 1 | 2011 | 168757 | 0.000 |
Why?
|